Your browser doesn't support javascript.
loading
Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study.
Lee, Min-Geol; Huang, Yu-Huei; Lee, Joo-Heung; Lee, Seung-Chul; Kim, Tae-Gyun; Aw, Derrick Chen-Wee; Bao, Weibin; Dee, Cathleen Michelle A; Guana, Adriana; Tsai, Tsen-Fang.
Afiliación
  • Lee MG; Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Huang YH; Department of Dermatology, Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Lee JH; Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee SC; Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea.
  • Kim TG; Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Aw DC; Division of Medicine, Sengkang General Hospital, Singapore City, Singapore.
  • Bao W; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Dee CMA; Novartis Singapore (Pte) Ltd, Singapore City, Singapore.
  • Guana A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
J Dermatol ; 46(9): 752-758, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31342560

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Ustekinumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Dermatol Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Ustekinumab / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Dermatol Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido